Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04683640 · ClinicalTrials.gov registry record · Phase 2

Latent Aging Mechanisms in Pain and Sleep

A Phase 2 study of Chronic Pain, sponsored by University of Florida.

Completed
Registry status
Phase 2
Development phase
33
Enrollment target
1
Study location

NCT04683640 is a Phase 2 study of Chronic Pain that has completed, run by University of Florida. The registered enrollment target is 33 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04683640, a Phase 2 study of Chronic Pain, has completed, sponsored by University of Florida.

COMPLETED
Registry status
Phase 2
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

Chronic pain is a serious public health problem in older adults depending on the pain condition, and the capacity to sleep properly changes with age. Given the potential mechanistic role of GABA (gamma-aminobutyric acid) in both conditions, based on our preliminary data, this proposal will determine the effect of oral GABA administration in sleep quality and pain in older adults with chronic pain and sleep disorders as well as to characterize the potential neurobiological mechanisms involved in both illnesses.

Conditions Studied

Interventions

  • DRUG Placebo
  • DIETARY_SUPPLEMENT GABA

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2021-04-02
Est. Completion 2024-05-30
Phase Phase 2

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT04683640

The ClinicalTrials.gov registry entry for NCT04683640 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (96% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04683640 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04683640 about?

NCT04683640 is a clinical study titled "Latent Aging Mechanisms in Pain and Sleep". Chronic pain is a serious public health problem in older adults depending on the pain condition, and the capacity to sleep properly changes with age. Given the potential mechanistic role of GABA (gamma-aminobutyric acid) in both conditions, based on our preliminary data, this proposal will determine...

What is the current status of trial NCT04683640?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 33 participants. The study started on 2021-04-02. Estimated completion is 2024-05-30.

What conditions does trial NCT04683640 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT04683640?

The interventions under investigation include: Placebo (DRUG), GABA (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04683640?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04683640 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.